scholarly journals Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

2021 ◽  
Vol 131 (22) ◽  
Author(s):  
Nan Jin ◽  
Bhumsuk Keam ◽  
Janice Cho ◽  
Michelle J. Lee ◽  
Hye Ryun Kim ◽  
...  
2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 5513-5513 ◽  
Author(s):  
T. Rampias ◽  
A. Giagini ◽  
K. Florou ◽  
P. Gouveris ◽  
E. Vaja ◽  
...  

2008 ◽  
Vol 88 (4) ◽  
pp. 342-353 ◽  
Author(s):  
Rifat Hasina ◽  
Mark E Whipple ◽  
Leslie E Martin ◽  
Winston Patrick Kuo ◽  
Lucila Ohno-Machado ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Marcus M. Monroe ◽  
Eric C. Anderson ◽  
Daniel R. Clayburgh ◽  
Melissa H. Wong

Accumulating evidence suggests that self-renewal and differentiation capabilities reside only in a subpopulation of tumor cells, termed cancer stem cells (CSCs), whereas the remaining tumor cell population lacks the ability to initiate tumor development or support continued tumor growth. In head and neck squamous cell carcinoma (HNSCC), as with other malignancies, cancer stem cells have been increasingly shown to have an integral role in tumor initiation, disease progression, metastasis and treatment resistance. In this paper we summarize the current knowledge of the role of CSCs in HNSCC and discuss the therapeutic implications and future directions of this field.


2006 ◽  
Vol 12 (5) ◽  
pp. 1441-1446 ◽  
Author(s):  
Wanglong Qiu ◽  
Frank Schönleben ◽  
Xiaojun Li ◽  
Daniel J. Ho ◽  
Lanny G. Close ◽  
...  

Cancers ◽  
2019 ◽  
Vol 11 (5) ◽  
pp. 616 ◽  
Author(s):  
Claudia Peitzsch ◽  
Jacqueline Nathansen ◽  
Sebastian I. Schniewind ◽  
Franziska Schwarz ◽  
Anna Dubrovska

Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed cancer worldwide. Despite advances in the treatment management, locally advanced disease has a poor prognosis, with a 5-year survival rate of approximately 50%. The growth of HNSCC is maintained by a population of cancer stem cells (CSCs) which possess unlimited self-renewal potential and induce tumor regrowth if not completely eliminated by therapy. The population of CSCs is not only a promising target for tumor treatment, but also an important biomarker to identify the patients at risk for therapeutic failure and disease progression. This review aims to provide an overview of the recent pre-clinical and clinical studies on the biology and potential therapeutic implications of HNSCC stem cells.


Head & Neck ◽  
2015 ◽  
Vol 37 (5) ◽  
pp. 763-770 ◽  
Author(s):  
Francesco Perri ◽  
Roberto Pacelli ◽  
Giuseppina Della Vittoria Scarpati ◽  
Laura Cella ◽  
Mario Giuliano ◽  
...  

2015 ◽  
Vol 22 (1) ◽  
pp. 35-40 ◽  
Author(s):  
Julie A. Theurer ◽  
William Stecho ◽  
John Yoo ◽  
Keith Kwan ◽  
Bret Wehrli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document